$PFE News Stock buybacks blamed for lack of U.
Post# of 74540
Posted On: 09/04/2014 11:52:46 AM
$PFE News
Stock buybacks blamed for lack of U.S. prosperity 4:51 p.m. Sept. 2, 2014 - Russ Britt
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
2 Compelling Reasons To Buy Pfizer 10:15 a.m. Today - Seeking Alpha
Australia Targets Multinational Tax Avoidance 5:13 a.m. Today - The Wall Street Journal Interactive Edition
Google, AbbVie in Research Pact 11:32 p.m. Sept. 3, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca Targeted U.S. to Fend Off Pfizer 8:24 p.m. Sept. 3, 2014 - The Wall Street Journal Interactive Edition
Triumeq cleared in Europe 9:30 a.m. Sept. 3, 2014 - Seeking Alpha
Bristol-Myers/Pfizer's Eliquis Encourages in VTE Analysis - Analyst Blog 6:50 p.m. Sept. 2, 2014 - Zacks.com
AstraZeneca Reports Data on Brilinta from ATLANTIC Study - Analyst Blog 6:40 p.m. Sept. 2, 2014 - Zacks.com
Baxter Will Remain Diversified and With Competitive Advantages 1:49 p.m. Sept. 2, 2014 - GuruFocus.com
Great Biotech Stocks for Retirement Investors 8:47 a.m. Sept. 2, 2014 - InvestorPlace.com
Pfizer: Prescription For A Strong Dividend Yield 11:23 p.m. Sept. 1, 2014 - Seeking Alpha
New Advice for Vaccines to Stave Off Pneumonia 4:55 p.m. Sept. 1, 2014 - The Wall Street Journal Interactive Edition
Retirement Strategy: The Buy The Dips Portfolio Continues To Surge 8:00 a.m. Sept. 1, 2014 - Seeking Alpha
Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - August Update 11:49 p.m. Aug. 29, 2014 - Seeking Alpha
Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog 6:10 p.m. Aug. 29, 2014 - Zacks.com
BioMed Realty Inks Lease Agreement with GlycoMimetics in MD - Analyst Blog 5:20 p.m. Aug. 29, 2014 - Zacks.com
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog 5:00 p.m. Aug. 29, 2014 - Zacks.com
Is GlaxoSmithKline A Solid Long-Term Investment? 1:46 p.m. Aug. 29, 2014 - Seeking Alpha
European Stocks See Tentative Rise 12:37 p.m. Aug. 29, 2014 - The Wall Street Journal Interactive Edition
There's No Need for Investors to Fear September 12:18 p.m. Aug. 29, 2014 - The Wall Street Journal Interactive Edition
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher 9:20 a.m. Today - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 10:00 a.m. Sept. 3, 2014 - BusinessWire - BZX
BIND Therapeutics Appoints Two New Board Members 8:30 a.m. Sept. 3, 2014 - BusinessWire - BZX
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 11:20 a.m. Aug. 29, 2014 - PR Newswire - PRF
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 10:13 a.m. Aug. 29, 2014 - PR Newswire - PRF
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease 1:15 p.m. Aug. 28, 2014 - BusinessWire - BZX
Global Diabetic Neuropathy Market 2014-2018 12:48 p.m. Aug. 28, 2014 - PR Newswire - PRF
Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation 8:00 a.m. Aug. 28, 2014 - BusinessWire - BZX
Upcoming Conference Schedule, Scholarship, Approved Supplemental New Drug Application, and Technical Updates - Research Reports on Gilead, AbbVie, Pfizer, Express Scripts and Bard 9:10 a.m. Aug. 27, 2014 - PR Newswire - PRF
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 4:55 p.m. Aug. 26, 2014 - PR Newswire - PRF
Diabetic Retinopathy Global Clinical Trials Review, H1, 2014 3:23 p.m. Aug. 26, 2014 - PR Newswire - PRF
Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen 8:01 a.m. Aug. 26, 2014 - BusinessWire - BZX
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014 2:44 p.m. Aug. 25, 2014 - PR Newswire - PRF
Arteriosclerosis Global Clinical Trials Review, H2, 2014 2:41 p.m. Aug. 25, 2014 - PR Newswire - PRF
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014 2:38 p.m. Aug. 25, 2014 - PR Newswire - PRF
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer 8:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Expanding IBD Research Through Collaboration 9:00 a.m. Aug. 20, 2014 - PR Newswire - PRF
Stock buybacks blamed for lack of U.S. prosperity 4:51 p.m. Sept. 2, 2014 - Russ Britt
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
2 Compelling Reasons To Buy Pfizer 10:15 a.m. Today - Seeking Alpha
Australia Targets Multinational Tax Avoidance 5:13 a.m. Today - The Wall Street Journal Interactive Edition
Google, AbbVie in Research Pact 11:32 p.m. Sept. 3, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca Targeted U.S. to Fend Off Pfizer 8:24 p.m. Sept. 3, 2014 - The Wall Street Journal Interactive Edition
Triumeq cleared in Europe 9:30 a.m. Sept. 3, 2014 - Seeking Alpha
Bristol-Myers/Pfizer's Eliquis Encourages in VTE Analysis - Analyst Blog 6:50 p.m. Sept. 2, 2014 - Zacks.com
AstraZeneca Reports Data on Brilinta from ATLANTIC Study - Analyst Blog 6:40 p.m. Sept. 2, 2014 - Zacks.com
Baxter Will Remain Diversified and With Competitive Advantages 1:49 p.m. Sept. 2, 2014 - GuruFocus.com
Great Biotech Stocks for Retirement Investors 8:47 a.m. Sept. 2, 2014 - InvestorPlace.com
Pfizer: Prescription For A Strong Dividend Yield 11:23 p.m. Sept. 1, 2014 - Seeking Alpha
New Advice for Vaccines to Stave Off Pneumonia 4:55 p.m. Sept. 1, 2014 - The Wall Street Journal Interactive Edition
Retirement Strategy: The Buy The Dips Portfolio Continues To Surge 8:00 a.m. Sept. 1, 2014 - Seeking Alpha
Retirement Strategy: ETF Only Portfolio Vs. Buy The Dips Portfolio - August Update 11:49 p.m. Aug. 29, 2014 - Seeking Alpha
Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog 6:10 p.m. Aug. 29, 2014 - Zacks.com
BioMed Realty Inks Lease Agreement with GlycoMimetics in MD - Analyst Blog 5:20 p.m. Aug. 29, 2014 - Zacks.com
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog 5:00 p.m. Aug. 29, 2014 - Zacks.com
Is GlaxoSmithKline A Solid Long-Term Investment? 1:46 p.m. Aug. 29, 2014 - Seeking Alpha
European Stocks See Tentative Rise 12:37 p.m. Aug. 29, 2014 - The Wall Street Journal Interactive Edition
There's No Need for Investors to Fear September 12:18 p.m. Aug. 29, 2014 - The Wall Street Journal Interactive Edition
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Upcoming Event, Drug Approval, Technical Updates, and Research Grant - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Thermo Fisher 9:20 a.m. Today - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 10:00 a.m. Sept. 3, 2014 - BusinessWire - BZX
BIND Therapeutics Appoints Two New Board Members 8:30 a.m. Sept. 3, 2014 - BusinessWire - BZX
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 11:20 a.m. Aug. 29, 2014 - PR Newswire - PRF
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN® 10:13 a.m. Aug. 29, 2014 - PR Newswire - PRF
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease 1:15 p.m. Aug. 28, 2014 - BusinessWire - BZX
Global Diabetic Neuropathy Market 2014-2018 12:48 p.m. Aug. 28, 2014 - PR Newswire - PRF
Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation 8:00 a.m. Aug. 28, 2014 - BusinessWire - BZX
Upcoming Conference Schedule, Scholarship, Approved Supplemental New Drug Application, and Technical Updates - Research Reports on Gilead, AbbVie, Pfizer, Express Scripts and Bard 9:10 a.m. Aug. 27, 2014 - PR Newswire - PRF
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 4:55 p.m. Aug. 26, 2014 - PR Newswire - PRF
Diabetic Retinopathy Global Clinical Trials Review, H1, 2014 3:23 p.m. Aug. 26, 2014 - PR Newswire - PRF
Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen 8:01 a.m. Aug. 26, 2014 - BusinessWire - BZX
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014 2:44 p.m. Aug. 25, 2014 - PR Newswire - PRF
Arteriosclerosis Global Clinical Trials Review, H2, 2014 2:41 p.m. Aug. 25, 2014 - PR Newswire - PRF
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014 2:38 p.m. Aug. 25, 2014 - PR Newswire - PRF
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer 8:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Expanding IBD Research Through Collaboration 9:00 a.m. Aug. 20, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼